Evidence map›Paper›PMID 25836419›Full record

ArticleNeurobiology of disease2015

Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients.

Paolo Santambrogio, Sabrina Dusi, Michela Guaraldo, Luisa Ida Rotundo, Vania Broccoli, Barbara Garavaglia, Valeria Tiranti, Sonia Levi

Open access · hybridAbstract read
In one paragraph

Article in Neurobiology of disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Exploring the causal impact of mitochondrial dysfunction on epilepsy: a mendelian randomization study.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  3. Review
  4. Article
  5. Endo-Lysosomal Network Disorder Reprograms Energy Metabolism in SorL1-Null Rat Hippocampus.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Bi-Allelic Mutations in ZebrafishInternational journal of molecular sciences · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. NovelFrontiers in aging neuroscience · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Paolo SantambrogioSan Raffaele Scientific Institute, Division of Neuroscience, 20132 Milano, Italy.
Sabrina DusiMolecular Neurogenetics Unit, Foundation IRCCS-Neurological Institute "Carlo Besta", 20126 Milano, Italy.
Michela GuaraldoSan Raffaele Scientific Institute, Division of Neuroscience, 20132 Milano, Italy; University Vita-Salute San Raffaele, 20132 Milano, Italy.
Luisa Ida RotundoSan Raffaele Scientific Institute, Division of Neuroscience, 20132 Milano, Italy.
Vania BroccoliSan Raffaele Scientific Institute, Division of Neuroscience, 20132 Milano, Italy.
Barbara GaravagliaMolecular Neurogenetics Unit, Foundation IRCCS-Neurological Institute "Carlo Besta", 20126 Milano, Italy.
Valeria TirantiMolecular Neurogenetics Unit, Foundation IRCCS-Neurological Institute "Carlo Besta", 20126 Milano, Italy.
Sonia LeviSan Raffaele Scientific Institute, Division of Neuroscience, 20132 Milano, Italy; University Vita-Salute San Raffaele, 20132 Milano, Italy. Electronic address: levi.sonia@hsr.it.
San Raffaele University of Rome · ITFondazione IRCCS Istituto Neurologico Carlo Besta · IT

Funding

European Research Council 340527Telethon GGP11088
6 · The paper itself

Abstract

Pantothenate kinase-associated neurodegeneration is an early onset autosomal recessive movement disorder caused by mutation of the pantothenate kinase-2 gene, which encodes a mitochondrial enzyme involved in coenzyme A synthesis. The disorder is characterised by high iron levels in the brain, although the pathological mechanism leading to this accumulation is unknown. To address this question, we tested primary skin fibroblasts from three patients and three healthy subjects, as well as neurons induced by direct fibroblast reprogramming, for oxidative status, mitochondrial functionality and iron parameters. The patients' fibroblasts showed altered oxidative status, reduced antioxidant defence, and impaired cytosolic and mitochondrial aconitase activities compared to control cells. Mitochondrial iron homeostasis and functionality analysis of patient fibroblasts indicated increased labile iron pool content and reactive oxygen species development, altered mitochondrial shape, decreased membrane potential and reduced ATP levels. Furthermore, analysis of induced neurons, performed at a single cell level, confirmed some of the results obtained in fibroblasts, indicating an altered oxidative status and signs of mitochondrial dysfunction, possibly due to iron mishandling. Thus, for the first time, altered biological processes have been identified in vitro in live diseased neurons. Moreover, the obtained induced neurons can be considered a suitable human neuronal model for the identification of candidate therapeutic compounds for this disease.

Indexed as

Aconitate HydrataseAdenosine TriphosphateAdultAnalysis of VarianceCells, CulturedEnergy MetabolismFibroblastsGlutathioneHumansInfant, NewbornIronLipMembrane Potential, MitochondrialMitochondriaMutationNeurodegenerative DiseasesAconitate HydrataseAdenosine TriphosphateGlutathioneIronpantothenate kinasePhosphotransferases (Alcohol Group Acceptor)Reactive Oxygen SpeciesInduced neuronsIron metabolismMitochondriaNBIAPANK2Reactive oxygen species

Identifiers

PMID25836419
PMCPMC4642744
OpenAlexW2021695917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.